PROK: ProKidney Corp - Class A
今日PROK汇率已更改11.31%。当日,交易品种以低点2.2200和高点2.5450进行交易。
关注ProKidney Corp - Class A动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
PROK新闻
- Aquestive Therapeutics (AQST) Reports Q4 Loss, Misses Revenue Estimates
- ProKidney Stock: Differentiated CKD Approach Positions Rilparencel Favorably (NASDAQ:PROK)
- ProKidney Corp. (PROK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- ProKidney Corp. (PROK) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:PROK) 2026-01-14
- H.C. Wainwright 给予 ProKidney 股票"买入"评级,目标价12美元
- H.C. Wainwright initiates ProKidney stock with Buy rating, $12 target
- This MYR Group Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday - Compass Minerals Intl (NYSE:CMP), MYR Group (NASDAQ:MYRG)
- ProKidney: Slow-Burning 'Buy' Opportunity Based On 2027 Approval Of Kidney Disease Therapy
- ProKidney Corp. (PROK) Presents at Morgan Stanley 23rd Annual
- ProKidney at Morgan Stanley Conference: Strategic Insights on CKD Therapy
- ProKidney Corp. (PROK) Presents At Citi's Biopharma Back To School Conference Transcript
- ProKidney at Citi’s Biopharma Back to School Conference: CKD Therapy Progress
- Social Capital's Chamath Palihapitiya is launching a new SPAC — it comes with a jarring warning for retail investors
- Meet the Biotech Stock That Rocketed 775% Higher
- PROKIDNEY CP (PROK) Upgraded to Strong Buy: What Does It Mean for the Stock?
- Best Momentum Stocks to Buy for July 17th
- This Biotech Stock Jumped Over 600% in Just Days After Releasing Promising Clinical Trial Data. And Its Market Cap Is Still Only $2 Billion. But Is It a Buy?
- New Strong Buy Stocks for July 17th
- ProKidney completes Delaware domestication and restructures corporate agreements
- ProKidney Corp. (PROK) is a Great Momentum Stock: Should You Buy?
- ProKidney stock soars after FDA confirms accelerated approval pathway
- Simulations Plus, FB Financial And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Blue Gold (NASDAQ:BGL), FB Financial (NYSE:FBK)
- ProKidney stock falls after FDA alignment on rilparencel approval pathway
- FDA confirms eGFR slope as acceptable endpoint for rilparencel approval
常见问题解答
PROK股票今天的价格是多少?
ProKidney Corp - Class A股票今天的定价为2.4600。它在2.2200 - 2.5450范围内交易,昨天的收盘价为2.2100,交易量达到1627。PROK的实时价格图表显示了这些更新。
ProKidney Corp - Class A股票是否支付股息?
ProKidney Corp - Class A目前的价值为2.4600。股息政策取决于公司,而投资者也会关注18.27%和USD。实时查看图表以跟踪PROK走势。
如何购买PROK股票?
您可以以2.4600的当前价格购买ProKidney Corp - Class A股票。订单通常设置在2.4600或2.4630附近,而1627和10.31%显示市场活动。立即关注PROK的实时图表更新。
如何投资PROK股票?
投资ProKidney Corp - Class A需要考虑年度范围2.0450 - 2.5450和当前价格2.4600。许多人在以2.4600或2.4630下订单之前,会比较13.89%和。实时查看PROK价格图表,了解每日变化。
ProKidney Corp - Class A股票的最高价格是多少?
在过去一年中,ProKidney Corp - Class A的最高价格是2.5450。在2.0450 - 2.5450内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪ProKidney Corp - Class A的绩效。
ProKidney Corp - Class A股票的最低价格是多少?
ProKidney Corp - Class A(PROK)的最低价格为2.0450。将其与当前的2.4600和2.0450 - 2.5450进行比较,可以发现潜在的长期切入点。观看PROK在图表上的实时走势以获取更多详细信息。
PROK股票是什么时候拆分的?
ProKidney Corp - Class A历史上曾经历过股票拆分。这些变化在公司行动后的、2.2100和18.27%中可见。
- 前一天收盘价
- 2.2100
- 开盘价
- 2.2300
- 卖价
- 2.4600
- 买价
- 2.4630
- 最低价
- 2.2200
- 最高价
- 2.5450
- 交易量
- 1.627 K
- 日变化
- 11.31%
- 月变化
- 13.89%
- 6个月变化
- 18.27%
- 年变化
- 18.27%
- 实际值
- 预测值
- 前值
- 实际值
- 预测值
- 前值
- 实际值
- 预测值
- 1.7%
- 前值
- 4.9%
- 实际值
- 预测值
- -0.1%
- 前值
- -1.9%
- 实际值
- 预测值
- 222 K
- 前值
- 212 K
- 实际值
- 预测值
- 1.836 M
- 前值
- 1.833 M
- 实际值
- 预测值
- 前值